–Study announced in conjunction with American Heart Association’s Scientific Sessions– –Researchers also presenting data on limitations of highly targeted screening strategies in familial hypercholesterolemia– PHILADELPHIA, Nov. 15, 2019 /PRNewswire/ — Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced Invitae Discover, a clinical research […]
